Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/apt.12825PMID 24890045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peptides targeting chemokine receptor CXCR4: structural behavior and biological binding studies

  2014cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Dysfunctional CD39 Regulatory T Cells and Aberrant Control of T-Helper Type 17 Cells in Autoimmune Hepatitis

  2014influential reference
• Hepatic inflammation and progressive liver fibrosis in chronic liver disease.

  2014cited by this paper
• Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis

  2014influential reference
• CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

  2014influential reference
• Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis

  2014cited by this paper
• The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets

  2014influential reference
• Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation.

  2014cited by this paper
• Hepatitis B virus X increases immune cell recruitment by induction of chemokine SDF‐1

  2014cited by this paper
• Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

  2014cited by this paper
• Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis

  2014cited by this paper
• Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels

  2014cited by this paper
• Chemokine–Chemokine Receptor CCL2–CCR2 and CX3CL1–CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis

  2014cited by this paper
• High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia

  2013cited by this paper
• Clinicopathological Significance of Serum Fractalkine in Primary Biliary Cirrhosis

  2013cited by this paper
• Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.

  2013cited by this paper
• Use of TNFα antagonists in refractory AIH: revealing the unforeseen.

  2013cited by this paper
• PPARγ Agonists in Adaptive Immunity: What Do Immune Disorders and Their Models Have to Tell Us?

  2013cited by this paper
• CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway.

  2013cited by this paper
• Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis

  2013cited by this paper
• Mucosal immunity in liver autoimmunity: a comprehensive review.

  2013cited by this paper
• Molecular Pathways: Hepatitis C Virus, CXCL10, and the Inflammatory Road to Liver Cancer

  2013cited by this paper
• CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid

  2013influential reference
• [Investigate circulating levels of chemokines and evaluate the correlation between these chemokines and liver function indicators in autoimmune hepatitis].

  2013cited by this paper
• Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function*

  2013cited by this paper
• CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil?

  2013cited by this paper
• Chemokines in tissue fibrosis.

  2013influential reference
• TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression.

  2013cited by this paper
• Review article: the management of autoimmune hepatitis beyond consensus guidelines

  2013cited by this paper
• Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy.

  2013cited by this paper
• CXCL14 is a natural inhibitor of the CXCL12–CXCR4 signaling axis

  2013cited by this paper
• Review article: autoimmune hepatitis – current management and challenges

  2013cited by this paper
• Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance

  2013cited by this paper
• Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia

  2012cited by this paper
• FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency.

  2012cited by this paper
• Regulatory T cells in autoimmune hepatitis.

  2012cited by this paper
• Primary immunodeficiency associated with defects in CD1 and CD1‐restricted T cells

  2012cited by this paper
• Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators.

  2012cited by this paper
• Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice

  2012cited by this paper
• Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.

  2012cited by this paper
• Drug choices in autoimmune hepatitis: Part B – nonsteroids

  2012cited by this paper
• Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil.

  2012cited by this paper
• Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis

  2012cited by this paper
• Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs

  2012cited by this paper
• A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.

  2012cited by this paper
• CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver

  2012cited by this paper
• Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part II.

  2012cited by this paper
• XCL1 and XCR1 in the immune system.

  2012cited by this paper
• T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

  2011cited by this paper
• Mechanism of regulation of autoimmunity by iNKT cells.

  2011cited by this paper
• British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis

  2011cited by this paper
• Peroxisome proliferator-activated receptor α agonists modulate Th1 and Th2 chemokine secretion in normal thyrocytes and Graves' disease.

  2011cited by this paper
• Suppression of innate immunity (natural killer cell/interferon‐γ) in the advanced stages of liver fibrosis in mice

  2011cited by this paper
• CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.

  2011cited by this paper
• Natural killer T cells in health and disease.

  2011cited by this paper
• Role of NKT cells in autoimmune liver disease.

  2011cited by this paper
• High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV/HCV co-infected patients with HCV genotype 1.

  2011cited by this paper
• Autoantigen‐specific regulatory T cells, a potential tool for immune‐tolerance reconstitution in type‐2 autoimmune hepatitis

  2011cited by this paper
• CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer

  2011cited by this paper
• Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells

  2011cited by this paper
• The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

  2011cited by this paper
• Interleukin-17 Contributes to the Pathogenesis of Autoimmune Hepatitis through Inducing Hepatic Interleukin-6 Expression

  2011cited by this paper
• CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

  2010cited by this paper
• Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B

  2010cited by this paper
• CX3CR1 and vascular adhesion protein‐1‐dependent recruitment of CD16+ monocytes across human liver sinusoidal endothelium

  2010cited by this paper
• CX3CL1‐CX3CR1 interaction prevents carbon tetrachloride‐induced liver inflammation and fibrosis in mice

  2010cited by this paper
• Diagnosis and management of autoimmune hepatitis

  2010cited by this paper
• The Role of Chemokines in the Recruitment of Lymphocytes to the Liver

  2010cited by this paper
• Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.

  2010cited by this paper
• Review article: the modern management of autoimmune hepatitis

  2010cited by this paper
• AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE CX3CL1 (Fractalkine): A Signpost for Biliary Inflammation in Primary Biliary Cirrhosis

  2010cited by this paper
• Accumulation of functional regulatory T cells in actively inflamed liver in mouse dendritic cell-based autoimmune hepatic inflammation.

  2010influential reference
• Chemokines in Liver Inflammation and Fibrosis

  2010cited by this paper
• Emerging Opportunities for Site-Specific Molecular and Cellular Interventions in Autoimmune Hepatitis

  2010cited by this paper
• CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune system

  2010cited by this paper
• Functional role of chemokines in liver disease models

  2010cited by this paper
• Aetiopathogenesis of autoimmune hepatitis.

  2010cited by this paper
• CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis

  2010cited by this paper
• IL-17 contributes to autoimmune hepatitis

  2010cited by this paper
• Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis.

  2010cited by this paper
• The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes

  2010cited by this paper
• The role of chemokines in the recruitment of lymphocytes to the liver.

  2010cited by this paper
• IL-17 contributes to autoimmune hepatitis

  2010cited by this paper
• Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.

  2010cited by this paper
• The interleukin‐17 pathway is involved in human alcoholic liver disease

  2009cited by this paper
• Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

  2009cited by this paper
• Angiogenesis in liver disease.

  2009cited by this paper
• CCR2 promotes hepatic fibrosis in mice

  2009cited by this paper
• CXCL10 and autoimmune diseases.

  2009cited by this paper
• CCR1 and CCR5 promote hepatic fibrosis in mice.

  2009cited by this paper
• Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.

  2009cited by this paper
• CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver

  2009cited by this paper
• CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis1

  2009cited by this paper
• Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis

  2009cited by this paper
• Hepatic stellate cells express functional CXCR4: Role in stromal cell–derived factor‐1α–mediated stellate cell activation

  2009cited by this paper
• Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production

  2009cited by this paper
• Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver.

  2009cited by this paper
• Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.

  2009cited by this paper
• Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients.

  2009cited by this paper
• Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells

  2009cited by this paper

• Circulating and Tissue Galectin-3 in Gastrointestinal Inflammation: Clinical Significance and Biomarker Potential

  2025cites this paper
• Pathogenesis, Non‐Invasive Assessments and Treatment of Hepatic Fibrosis in Autoimmune Liver Diseases

  2025cites this paper
• Liver transplant-facilitated CD161+Vα7.2+ MAIT cell recovery demonstrates clinical benefits in hepatic failure patients

  2025cites this paper
• RANTES, IP-10 and MCP-1 Profiles in Patients with Autoimmune Hepatitis (AIH) at Baseline and During Immunosuppressive Treatment

  2025cites this paper
• Single-Cell RNA Sequencing Reveals Peripheral Immune Cell Senescence and Inflammatory Phenotypes in Patients with Premature Ovarian Failure

  2025cites this paper
• Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions

  2025cites this paper
• A multilevel analysis of the genetic association between inflammatory bowel disease and primary sclerosing cholangitis.

  2025cites this paper
• CCL17 as an Inflammatory Biomarker Enhances Cardiovascular Risk Stratification: a Prospective Cohort Study

  2025cites this paper
• Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siRIPK3.

  2024cites this paper
• Systemic inflammatory factors in non-alcoholic steatohepatitis-induced hepatocellular carcinoma: A bidirectional Mendelian randomization analysis

  2024cites this paper
• B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.

  2024cites this paper
• Vagus nerve modulates acute-on-chronic liver failure progression via CXCL9

  2024cites this paper
• Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis.

  2023cites this paper
• Anti-ribosomal P (anti-P) antibodies in patients with autoimmune hepatitis

  2023cites this paper
• YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

  2023cites this paper
• CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis

  2023cites this paper
• Role of the CXCR6/CXCL16 axis in autoimmune diseases.

  2023cites this paper
• Transcriptional analysis reveals distinct gene expression profiles of three bowenoid papulosis patients

  2023cites this paper
• Identification of hepatocyte immune response in Autoimmune Hepatitis from human plasma cfChIP-seq

  2023cites this paper
• The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis

  2023cites this paper
• Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition

  2023cites this paper
• Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

  2022cites this paper
• Topics in Antiviral Medicine

  2022cites this paper
• Expression of HLA and Autoimmune Pathway Genes in Liver Biopsies of Young Subjects With Autoimmune Hepatitis Type 1

  2022cites this paper
• Advancing Biologic Therapy for Refractory Autoimmune Hepatitis

  2022cites this paper
• HIV and liver disease: a comprehensive update.

  2022cites this paper
• Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis

  2022cites this paper
• The synergistic ameliorative activity of peroxisome proliferator‐activated receptor‐alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance

  2022cites this paper
• Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes.

  2022cites this paper
• The Potential Role of Korean Mistletoe Extract as an Anti-Inflammatory Supplementation

  2021cites this paper
• Role of the chemokine system in liver fibrosis: a narrative review

  2021influential citation
• Autoimmune Hepatitis

  2021cites this paper
• Review article: targeting the B cell activation system in autoimmune hepatitis

  2021cites this paper
• Protective Effects of Cinnamaldehyde on the Inflammatory Response, Oxidative Stress, and Apoptosis in Liver of Salmonella typhimurium-Challenged Mice

  2021cites this paper
• Anti-Ribosomal P (Anti-P) Antibodies in Autoimmune Hepatitis Patients

  2021cites this paper
• ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells-of-origin

  2021cites this paper
• The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder.

  2021cites this paper
• Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease

  2021cites this paper
• Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis

  2021cites this paper
• The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma

  2020cites this paper
• Using evasins to target the chemokine network in inflammation.

  2020cites this paper
• Total glucosides of paeony decreases apoptosis of hepatocytes and inhibits maturation of dendritic cells in autoimmune hepatitis.

  2020cites this paper
• TNF Receptor:Fc Fusion Protein Downregulates RANKL/OPG Ratio by Inhibiting CXCL16/CXCR6 in Active Ankylosing Spondylitis.

  2020cites this paper
• Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis

  2020cites this paper
• Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice

  2020cites this paper
• ChIP-seq of plasma cell-free nucleosomes identifies cell-of-origin gene expression programs

  2020cites this paper
• CX3CL1–CX3CR1 Axis: A New Player in Coeliac Disease Pathogenesis

  2019cites this paper
• Qianggan extract improved nonalcoholic steatohepatitis by modulating lncRNA/circRNA immune ceRNA networks

  2019cites this paper
• ChIP-seq of plasma cell-free nucleosomes identifies cell-of-origin gene expression programs

  2019cites this paper
• Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors

  2019cites this paper
• Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma.

  2019cites this paper
• Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions

  2019cites this paper
• Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases

  2019cites this paper
• Revisión de tema: hepatitis autoinmune

  2018cites this paper
• Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis

  2018cites this paper
• Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management

  2018cites this paper
• Epigenetic changes and their implications in autoimmune hepatitis

  2018cites this paper
• Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management

  2018cites this paper
• Opposing Actions of Developmental Trichloroethylene and High-Fat Diet Coexposure on Markers of Lipogenesis and Inflammation in Autoimmune-Prone Mice

  2018cites this paper
• Immunopathogenesis of Autoimmune Liver Damage

  2017cites this paper
• Evolving paradigm of treatment for autoimmune hepatitis

  2017cites this paper
• Expolysaccharides from Bifidobacterium animalis RH activates RAW 264.7 macrophages through toll-like receptor 4

  2017cites this paper
• Review article: next‐generation transformative advances in the pathogenesis and management of autoimmune hepatitis

  2017cites this paper
• Cerebrospinal Fluid Chemokine (C-C Motif) Ligand 2 Is an Early-Response Biomarker for Blast-Overpressure-Wave–Induced Neurotrauma in Rats

  2017cites this paper
• Targeting Hepatic Fibrosis in Autoimmune Hepatitis

  2016influential citation
• Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis

  2016cites this paper
• Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level and high‐sensitivity C‐reactive protein concentration in autoimmune hepatitis

  2016cites this paper
• Mincle Signaling Promotes Con A Hepatitis

  2016cites this paper
• Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions

  2016cites this paper
• B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis

  2016cites this paper
• Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells

  2016cites this paper
• NK Cell Subtypes as Regulators of Autoimmune Liver Disease

  2016cites this paper
• CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction

  2016cites this paper
• Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications

  2015influential citation
• Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice.

  2015cites this paper
• Galectin-3 in autoimmunity and autoimmune diseases

  2015cites this paper
• Transitioning from Idiopathic to Explainable Autoimmune Hepatitis

  2015cites this paper
• Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis

  2015influential citation
• Deficiency of iPLA2β Primes Immune Cells for Proinflammation: Potential Involvement in Age-Related Mesenteric Lymph Node Lymphoma

  2015cites this paper
• The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction.

  2015cites this paper
• Zinc improves the immune function and the proliferation of lymphocytes in Cadmium-treated rats

  2014cites this paper
• Current and prospective pharmacotherapy for autoimmune hepatitis

  2014cites this paper
• Targeting Apoptosis in Autoimmune Hepatitis

  2014cites this paper